Private Market View

Aradigm (Enterprise Systems (Healthcare))

Bethesda, MD · Founded 2024 · Privately Held (backing)

Last price · $/share
Implied valuation
$106.0M
Total raised
$25.0M
Last round

Key facts

  • Aradigm (Enterprise Systems (Healthcare))’s last known valuation is $106.0M (Dec 2025).
  • It has raised $25.0M; the latest was Early Stage VC ($20.0M) in Dec 2025.
  • Notable investors include Andreessen Horowitz, Frist Cressey Ventures, Morgan Health.
  • 1 institutional filer reports fund marks on Aradigm (Enterprise Systems (Healthcare)) across 4 filings.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 3 names
  • ·Watchlist + deal alerts for Aradigm (Enterprise Systems (Healthcare))
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Aradigm (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Aradigm (Enterprise Systems (Healthcare))

Developer of a cell and gene therapy access and financing platform designed to support sustainable coverage of high-cost medicines. The company combines a carved-out delivery and payment model, predictable pricing structures, and coordinated engagement across payers, employers, providers, manufacturers, and patients, enabling health insurers, employer groups, and healthcare systems to manage financial risk and expand patient access to advanced therapies.

Sector
Healthcare
HQ
Bethesda, MD, United States
Founded
2024
Ownership
Privately Held (backing)
PA Mark — not yet priced

Aradigm (Enterprise Systems (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Aradigm (Enterprise Systems (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

1 filers · latest Aug 2025

1 SEC-registered fund reported 4 fair-value marks on Aradigm (Enterprise Systems (Healthcare)) between May 2025 and Aug 2025. Filer-level marks and implied $/share are available to Pro members.